Treatment of secondary hyperparathyroidism with intermittent oral high doses of 1-alpha-OHD3 plus pharmacological dose of 24,25(OH)2D3.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/FEC76D76.svg?ark=w1%2F20260515%2FFEC76D76)](https://nobleid.org/work/w1/20260515/FEC76D76)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors